Publications Database

Malone R. P. , Waheed A. (2009)

The role of antipsychotics in the management of behavioural symptoms in children and adolescents with autism.

Drugs

69(5), pp. 535-548.

Read Abstract (New Window)

Malow B. A. et al. (2012)

A practice pathway for the identification, evaluation, and management of insomnia in children and adolescents with autism spectrum disorders.

Pediatrics

130 S106-124.

Read Abstract (New Window) Read Full (New Window)

Marrus N. et al. (2014)

Lack of effect of risperidone on core autistic symptoms: data from a longitudinal study.

Journal of Child and Adolescent Psychopharmacology

November, 24(9), pp. 513-518.

Read Abstract (New Window)

Martin A. et al. (2004)

Weight and leptin changes among risperidone-treated youths with autism: 6-month prospective data.

American Journal of Psychiatry

161(6), pp. 1125-1127

Read Abstract (New Window) Read Full (New Window)

Masi G. et al. (2003)

A 3-year naturalistic study of 53 preschool children with pervasive developmental disorders treated with risperidone.

Journal of Clinical Psychiatry

64(9), pp. 1039-1047

Read Abstract (New Window)

Masi G. et al. (2001)

Open trial of risperidone in 24 young children with pervasive developmental disorders.

Journal of the American Academy of Child and Adolescent Psychiatry

40(10), pp. 1206-1214

Read Abstract (New Window)

Masi G. et al. (2001)

Risperidone monotherapy in preschool children with pervasive developmental disorders.

June, 16(6), pp. 395-400.

Read Abstract (New Window)

Masliyah T. , Ad-Dab'bagh Y. (2011)

Low-dose risperidone-induced oculogyric crises in an adolescent male with autism, tourette's and developmental delay.

Journal of the Canadian Academy of Child and Adolescent Psychiatry

20(3), pp. 214-216

Read Abstract (New Window) Read Full (New Window)

Matson J. L. et al. (2011)

Issues in the management of challenging behaviours of adults with autism spectrum disorder.

CNS Drugs

25(7), pp. 597-606

Read Abstract (New Window)

McCracken J. T. et al. (2002)

Risperidone in children with autism and serious behavioral problems.

New England Journal of Medicine

347(5), pp. 314-321

Read Abstract (New Window) Read Full (New Window)

McDougle C. J. et al. (1998)

A double-blind, placebo-controlled study of risperidone in adults with autistic disorder and other pervasive developmental disorders.

Archives of General Psychiatry

55(7), pp. 633-641

Read Abstract (New Window) Read Full (New Window)

McDougle C. J. et al. (2008)

Atypical antipsychotics in children and adolescents with autistic and other pervasive developmental disorders.

Journal of Clinical Psychiatry

69 pp.15-20

Read Abstract (New Window)

McDougle C. J. et al. (2000)

Research Units on Pediatric Psychopharmacology (RUPP) Autism Network. Background and rationale for an initial controlled study of risperidone.

Child and Adolescent Psychiatric Clinics of North America

January, 9(1), pp. 201-224.

Read Abstract (New Window)

McDougle C. J. et al. (2005)

Risperidone for the core symptom domains of autism: results from the study by the Autism Network of the Research Units on Pediatric Psychopharmacology.

American Journal of Psychiatry

162(6), pp. 1142-1148

Read Abstract (New Window) Read Full (New Window)

McDougle C. J. et al. (1997)

Risperidone treatment of children and adolescents with pervasive developmental disorders: A prospective, open-label study.

Journal of the American Academy of Child and Adolescent Psychiatry

36 pp. 685-693

Read Abstract (New Window)

Mills R. , Marchant S. (2011)

Intervention in autism: a brief review of the literature.

Tizard Learning Disability Review

16(4), pp.20 - 35

Read Abstract (New Window)

Miral S. et al. (2008)

Risperidone versus haloperidol in children and adolescents with AD: a randomized, controlled, double-blind trial.

European Child and Adolescent Psychiatry

17(1), pp. 1-8.

Read Abstract (New Window)

Mohammadi M. et al. (2013)

Double-blind, placebo-controlled trial of risperidone plus amantadine in children with autism: a 10-week randomized study.

Clinical Neuropharmacology

36(6), pp. 179-184.

Read Abstract (New Window)

Mohiuddin S. , Ghaziuddin M. (2013)

Psychopharmacology of autism spectrum disorders: A selective review.

Autism

17(6), pp. 645-654.

Read Abstract (New Window)

Mukaddes N. M. , Abali O. , Gurkan K. (2004)

Short-term efficacy and safety of risperidone in young children with autistic disorder (AD).

World Journal of Bilogical Psychiatry

5(4), pp. 211-214

Read Abstract (New Window)